Peregrine Pharmaceuticals Inc. (CDMO)

Last Three Months

23-Aug-24 -- 22-Nov-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Strong Sell

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

21

0

3

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
11-Oct-24 7:37 PM View:	10-Oct-24 Option Sale ($172.59K)	Green Nicholas Stewart President & CEO Director		Peregrine Pharmaceuticals Inc. - CDMO	7% 212.31K to 226.65K	0	0	--	--	Show Txns Hide Txns

11-Oct-24 7:38 PM View:	10-Oct-24 Option Sale ($2.02K)	Richieri Richard A. Chief Operations Officer		Peregrine Pharmaceuticals Inc. - CDMO	9% 41.19K to 44.92K	0	0	--	--	Show Txns Hide Txns

15-Oct-24 7:40 PM View:	14-Oct-24 Option Sale ($1.21K)	Kwietniak Matthew R. Chief Commercial Officer		Peregrine Pharmaceuticals Inc. - CDMO	9% 23.41K to 25.41K	0	0	--	--	Show Txns Hide Txns